Cogent Biosciences, Inc.
COGT
$12.23
$0.443.73%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 13.38M | 11.90M | 11.69M | 11.80M | 10.09M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 75.58M | 74.93M | 73.73M | 75.41M | 64.39M |
| Operating Income | -75.58M | -74.93M | -73.73M | -75.41M | -64.39M |
| Income Before Tax | -73.53M | -71.99M | -67.93M | -70.63M | -58.95M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -73.53M | -71.99M | -67.93M | -70.63M | -58.95M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -73.53M | -71.99M | -67.93M | -70.63M | -58.95M |
| EBIT | -75.58M | -74.93M | -73.73M | -75.41M | -64.39M |
| EBITDA | -74.93M | -74.29M | -73.11M | -74.79M | -63.78M |
| EPS Basic | -0.64 | -0.63 | -0.61 | -0.64 | -0.59 |
| Normalized Basic EPS | -0.40 | -0.40 | -0.35 | -0.40 | -0.37 |
| EPS Diluted | -0.64 | -0.63 | -0.61 | -0.64 | -0.59 |
| Normalized Diluted EPS | -0.40 | -0.40 | -0.35 | -0.40 | -0.37 |
| Average Basic Shares Outstanding | 114.54M | 113.38M | 111.45M | 110.17M | 99.24M |
| Average Diluted Shares Outstanding | 114.54M | 113.38M | 111.45M | 110.17M | 99.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |